Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-049130

President & CEO sold 30,000 shares at $82.63 ($2,478,900)

From the SEC's structured data for this filing

Trades in this filing

KAKKIS EMIL D · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-01 Sale : show line 1 in the form −30,000 $82.63 $2,478,900 2,389,741 I
Open-market sales · 30,000 sh · avg $82.63 · $2,478,900
Loading xslF345X03/doc4.xml…